Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership2,205,758 shares
Latest Disclosed Value $ 145,381,509
Goldman Sachs Group Inc ownership in 1CYTK / Cytokinetics, Incorporated

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 2,205,758 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $119,110,932 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 2,371,647 shares of Cytokinetics, Incorporated. This represents a change in shares of -6.99% during the quarter. The current value of the position is $137,462,839 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (1CYTK) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 250,000 of underlying shares valued at $16,477,500 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS CMN 23282W605 2,205,758 -165,889 -6.99 145,382 -3.53 0.0039
2026-02-10 2025-12-31 13F CYTOKINETICS CMN 23282W605 2,371,647 736,924 45.08 150,694 67.73 0.0186
2025-11-14 2025-09-30 13F CYTOKINETICS CMN 23282W605 1,634,723 360,740 28.32 89,844 113.45 0.0110
2025-08-14 2025-06-30 13F CYTOKINETICS CMN 23282W605 1,273,983 -88,975 -6.53 42,092 -23.16 0.0057
2025-06-27 2025-03-31 13F/A-2 CYTOKINETICS CMN 23282W605 1,362,958 157,527 13.07 54,777 -3.40 0.0089
2025-05-16 2025-03-31 13F/A-1 CYTOKINETICS CMN 23282W605 1,362,958 157,527 54,777 0.0023
2025-05-09 2025-03-31 13F CYTOKINETICS CMN 23282W605 1,382,558 177,127 55,565 0.0017
2025-02-11 2024-12-31 13F CYTOKINETICS CMN 23282W605 1,205,431 20,642 1.74 56,703 -9.36 0.0089
2024-11-14 2024-09-30 13F CYTOKINETICS CMN 23282W605 1,184,789 46,635 4.10 62,557 1.44 0.0101
2024-08-13 2024-06-30 13F CYTOKINETICS CMN 23282W605 1,138,154 446,705 64.60 61,665 27.20 0.0104
2024-05-15 2024-03-31 13F CYTOKINETICS CMN 23282W605 691,449 -123,995 -15.21 48,477 -28.80 0.0086
2024-05-14 2023-12-31 13F/A-2 CYTOKINETICS CMN 23282W605 815,444 105,994 14.94 68,081 225.75 0.0125
2024-03-01 2023-12-31 13F/A-1 CYTOKINETICS CMN 23282W605 815,444 68,081
2024-02-13 2023-12-31 13F CYTOKINETICS CMN 23282W605 815,444 105,994 68,081 0.0032
2024-05-15 2023-09-30 13F/A-1 CYTOKINETICS CMN 23282W605 709,450 -396,788 -35.87 20,900 -42.08 0.0044
2023-11-14 2023-09-30 13F CYTOKINETICS CMN 23282W605 709,450 -396,788 20,900 0.0042
2024-05-14 2023-06-30 13F/A-1 CYTOKINETICS CMN 23282W605 1,106,238 31,714 2.95 36,085 -4.57 0.0077
2023-08-15 2023-06-30 13F CYTOKINETICS CMN 23282W605 1,106,238 31,714 36,085 0.0073
2024-05-14 2023-03-31 13F/A-1 CYTOKINETICS CMN 23282W605 1,074,524 164,273 18.05 37,812 -9.34 0.0087
2023-05-11 2023-03-31 13F CYTOKINETICS CMN 23282W605 1,074,524 164,273 37,812 0.0081
2024-05-14 2022-12-31 13F/A-1 CYTOKINETICS CMN 23282W605 910,251 232,167 34.24 41,708 130,234.38 0.0102
2023-02-13 2022-12-31 13F CYTOKINETICS CMN 23282W605 910,251 232,167 41,708 0.0093
2024-05-14 2022-09-30 13F/A-1 CYTOKINETICS CMN 23282W605 678,084 207,331 44.04 33 77.78 0.0083
2022-11-14 2022-09-30 13F CYTOKINETICS CMN 23282W605 678,084 207,331 32,853 0.0076
2024-05-14 2022-06-30 13F/A-2 CYTOKINETICS CMN 23282W605 470,753 -190,693 -28.83 18 -99.93 0.0046
2022-08-18 2022-06-30 13F/A-1 CYTOKINETICS CMN 23282W605 470,753 -190,693 18,496 0.0042
2022-08-15 2022-06-30 13F CYTOKINETICS CMN 23282W605 470,753 -190,693 18,496 0.0042
2022-05-16 2022-03-31 13F CYTOKINETICS CMN 23282W605 661,446 102,742 18.39 24,347 -4.39 0.0051
2022-02-17 2021-12-31 13F/A-1 CYTOKINETICS CMN 23282W605 558,704 -425,761 -43.25 25,466 -27.62 0.0051
2022-02-14 2021-12-31 13F CYTOKINETICS CMN 23282W605 558,704 -425,761 25,466 0.0015
2022-01-20 2021-09-30 13F/A-1 CYTOKINETICS CMN 23282W605 984,465 421,962 75.02 35,184 216.06 0.0075
2021-11-10 2021-09-30 13F CYTOKINETICS CMN 23282W605 984,465 421,962 35,184 0.0074
2021-08-13 2021-06-30 13F CYTOKINETICS CMN 23282W605 562,503 -242,785 -30.15 11,132 -40.57 0.0025
2021-05-17 2021-03-31 13F CYTOKINETICS CMN 23282W605 805,288 -18,476 -2.24 18,731 9.42 0.0047
2021-02-12 2020-12-31 13F CYTOKINETICS CMN 23282W605 823,764 -75,067 -8.35 17,118 -12.03 0.0044
2020-11-13 2020-09-30 13F CYTOKINETICS CMN 23282W605 898,831 84,192 10.33 19,459 1.34 0.0055
2020-08-12 2020-06-30 13F CYTOKINETICS CMN 23282W605 814,639 332,290 68.89 19,201 237.63 0.0058
2020-05-15 2020-03-31 13F CYTOKINETICS CMN 23282W605 482,349 155,047 47.37 5,687 63.75 0.0020
2020-02-14 2019-12-31 13F CYTOKINETICS CMN 23282W605 327,302 189,598 137.69 3,473 121.49 0.0009
2019-11-14 2019-09-30 13F CYTOKINETICS CMN 23282W605 137,704 35,032 34.12 1,568 35.76 0.0005
2019-08-14 2019-06-30 13F CYTOKINETICS CMN 23282W605 102,672 -134,157 -56.65 1,155 -39.72 0.0003
2019-05-15 2019-03-31 13F CYTOKINETICS CMN 23282W605 236,829 67,642 39.98 1,916 79.23 0.0006
2019-02-14 2018-12-31 13F CYTOKINETICS CMN 23282W605 169,187 11,028 6.97 1,069 -31.39 0.0003
2018-11-14 2018-09-30 13F CYTOKINETICS CMN 23282W605 158,159 -140,492 -47.04 1,558 -37.15 0.0004
2018-08-14 2018-06-30 13F CYTOKINETICS CMN 23282W605 298,651 -55,612 -15.70 2,479 -2.82 0.0007
2018-05-15 2018-03-31 13F CYTOKINETICS CMN 23282W605 354,263 -63,334 -15.17 2,551 -25.04 0.0007
2018-02-14 2017-12-31 13F CYTOKINETICS CMN 23282W605 417,597 73,031 21.20 3,403 -31.89 0.0008
2017-11-14 2017-09-30 13F CYTOKINETICS CMN 23282W605 344,566 58,548 20.47 4,996 44.35 0.0012
2017-08-14 2017-06-30 13F CYTOKINETICS CMN 23282W605 286,018 234,588 456.13 3,461 423.60 0.0009
2017-05-18 2017-03-31 13F/A-1 CYTOKINETICS CMN 23282W605 51,430 -20,061 -28.06 661 -23.94 0.0002
2017-05-15 2017-03-31 13F CYTOKINETICS CMN 23282W605 51,430 661
2017-02-14 2016-12-31 13F CYTOKINETICS CMN 23282W605 71,491 -61,871 -46.39 869 -29.00 0.0002
2016-11-14 2016-09-30 13F CYTOKINETICS CMN 23282W605 133,362 30,523 29.68 1,224 25.41 0.0004
2016-08-15 2016-06-30 13F CYTOKINETICS CMN 23282W605 102,839 102,839 0.00 976 0.0003
2016-05-13 2016-03-31 13F CYTOKINETICS CMN 23282W605 0 -35,554 -100.00 0 -100.00
2016-02-16 2015-12-31 13F CYTOKINETICS CMN 23282W605 35,554 19,420 120.37 372 244.44 0.0001
2015-11-13 2015-09-30 13F CYTOKINETICS CMN 23282W605 16,134 9,099 129.34 108 129.79 0.0000
2015-08-14 2015-06-30 13F CYTOKINETICS CMN 23282W605 7,035 2,695 62.10 47 62.07 0.0000
2015-05-15 2015-03-31 13F CYTOKINETICS CMN 23282W605 4,340 -74,312 -94.48 29 -95.40 0.0000
2015-02-13 2014-12-31 13F CYTOKINETICS CMN 23282W605 78,652 1,182 1.53 630 130.77 0.0002
2014-11-14 2014-09-30 13F CYTOKINETICS CMN 23282W605 77,470 62,473 416.57 273 279.17 0.0001
2014-08-14 2014-06-30 13F CYTOKINETICS CMN 23282W605 14,997 -30,830 -67.27 72 -83.45 0.0000
2014-05-15 2014-03-31 13F CYTOKINETICS CMN 23282W605 45,827 35,244 333.02 435 443.75 0.0001
2013-11-14 2013-09-30 13F CYTOKINETICS CMN 23282W605 10,583 10,583 -81.15 80 116.22 0.0000
2013-08-14 2013-06-30 13F CYTOKINETICS CMN 23282W100 0 -56,132 -100.00 0 -100.00
2013-06-14 2012-12-31 13F/A-1 CYTOKINETICS CMN 23282W100 56,132 -586 -1.03 37 -21.28 0.0000
2013-06-14 2012-09-30 13F/A-2 CYTOKINETICS CMN 23282W100 56,718 -49 -0.09 47 30.56 0.0000
2013-06-14 2012-06-30 13F/A-2 CYTOKINETICS CMN 23282W100 56,767 -20,595 -26.62 36 -59.55 0.0000
2013-06-14 2012-03-31 13F/A-1 CYTOKINETICS CMN 23282W100 77,362 77,362 89 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CYTOKINETICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-10 2025-12-31 13F CYTOKINETICS CMN Call 35,000 16.67 2,224 34.89 n/a n/a n/a
2025-11-14 2025-09-30 13F CYTOKINETICS CMN Call 30,000 -23.47 1,649 27.26 n/a n/a n/a
2025-08-14 2025-06-30 13F CYTOKINETICS CMN Call 39,200 330.77 1,295 254.79 n/a n/a n/a
2025-05-16 2025-03-31 13F/A CYTOKINETICS CMN Call 9,100 366 n/a n/a n/a
2025-06-27 2025-03-31 13F/A CYTOKINETICS CMN Call 9,100 366 n/a n/a n/a
2025-02-11 2024-12-31 13F CYTOKINETICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS CMN Call 47,500 -27.26 2,508 -29.09 n/a n/a n/a
2024-08-13 2024-06-30 13F CYTOKINETICS CMN Call 65,300 262.78 3,538 180.49 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS CMN Call 18,000 -91.09 1,262 -92.53 n/a n/a n/a
2024-03-01 2023-12-31 13F/A CYTOKINETICS CMN Call 202,100 16,873 n/a n/a n/a
2024-05-14 2023-12-31 13F/A CYTOKINETICS CMN Call 202,100 16,873 n/a n/a n/a
2024-02-13 2023-12-31 13F CYTOKINETICS CMN Call 202,100 16,873 n/a n/a n/a
2021-02-12 2020-12-31 13F CYTOKINETICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F CYTOKINETICS CMN Call 107,300 2,323 n/a n/a n/a
2017-02-14 2016-12-31 13F CYTOKINETICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F CYTOKINETICS CMN Call 26,800 246 n/a n/a n/a
2015-11-13 2015-09-30 13F CYTOKINETICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F CYTOKINETICS CMN Call 75,000 0.00 504 -0.98 n/a n/a n/a
2015-05-15 2015-03-31 13F CYTOKINETICS CMN Call 75,000 -25.00 509 -36.45 n/a n/a n/a
2015-02-13 2014-12-31 13F CYTOKINETICS CMN Call 100,000 801 n/a n/a n/a
2014-11-14 2014-09-30 13F CYTOKINETICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F CYTOKINETICS CMN Call 38,200 -77.30 183 -88.56 n/a n/a n/a
2014-05-15 2014-03-31 13F CYTOKINETICS CMN Call 168,300 1,599 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CYTOKINETICS CMN Put 250,000 34.12 16,478 39.13 n/a n/a n/a
2026-02-10 2025-12-31 13F CYTOKINETICS CMN Put 186,400 11,844 n/a n/a n/a
2025-08-14 2025-06-30 13F CYTOKINETICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-16 2025-03-31 13F/A CYTOKINETICS CMN Put 10,500 422 n/a n/a n/a
2025-06-27 2025-03-31 13F/A CYTOKINETICS CMN Put 10,500 422 n/a n/a n/a
2024-11-14 2024-09-30 13F CYTOKINETICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F CYTOKINETICS CMN Put 19,400 7.78 1,051 -16.65 n/a n/a n/a
2024-05-15 2024-03-31 13F CYTOKINETICS CMN Put 18,000 1,262 n/a n/a n/a
2018-02-14 2017-12-31 13F CYTOKINETICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F CYTOKINETICS CMN Put 50,000 725 n/a n/a n/a
2015-11-13 2015-09-30 13F CYTOKINETICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F CYTOKINETICS CMN Put 75,000 0.00 504 -0.98 n/a n/a n/a
2015-05-15 2015-03-31 13F CYTOKINETICS CMN Put 75,000 -25.00 509 -36.45 n/a n/a n/a
2015-02-13 2014-12-31 13F CYTOKINETICS CMN Put 100,000 801 n/a n/a n/a
2014-08-14 2014-06-30 13F CYTOKINETICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F CYTOKINETICS CMN Put 451,900 4,293 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.